<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Midkine is a <z:chebi fb="5" ids="28304">heparin</z:chebi>-binding growth factor having various biological activities including chemotaxis of inflammatory cells, <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> and migration of neuronal cells </plain></SENT>
<SENT sid="1" pm="."><plain>These biological activities are expected to have a great impact on the pathology of <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> in <z:hpo ids='HP_0011011'>subacute</z:hpo> phase </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, we investigated the effect of post-ischemic gene transfer of midkine in the phase </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">Brain ischemia</z:e> was produced by the photothrombotic distal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in spontaneously hypertensive rats </plain></SENT>
<SENT sid="4" pm="."><plain>We measured cerebral blood flow by laser Doppler flowmetry </plain></SENT>
<SENT sid="5" pm="."><plain>At 90 min after induction of <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e>, adenovirus vectors encoding mouse midkine (AdMK) or enhanced green fluorescence protein (AdGFP) were injected into the lateral ventricle </plain></SENT>
<SENT sid="6" pm="."><plain>At 7 days after <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e>, the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, <z:mp ids='MP_0001845'>inflammation</z:mp> and neuronal regeneration were evaluated </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: There were no differences in cerebral blood flow changes between AdMK and AdGFP groups </plain></SENT>
<SENT sid="8" pm="."><plain>However, <z:mpath ids='MPATH_124'>infarct</z:mpath> volume of AdMK group was significantly smaller than AdGFP group by 33% </plain></SENT>
<SENT sid="9" pm="."><plain>The vascular density, the numbers of leukocytes in blood vessels, infiltrated macrophages and proliferated neuronal precursor cells were not significantly different between both groups </plain></SENT>
<SENT sid="10" pm="."><plain>Contrastingly the numbers of migrating neuronal precursor cells toward the <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> were significantly increased in AdMK group than AdGFP group </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Neuroprotective effect of midkine gene transfer persisted until the <z:hpo ids='HP_0011011'>subacute</z:hpo> phase of <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Midkine may contribute to neuronal regeneration </plain></SENT>
<SENT sid="13" pm="."><plain>These results suggest the usefulness of midkine gene transfer for treatment of <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
</text></document>